(Stockholm, 4 April 2023) There is an urgent need to understand how a range of emerging ecological challenges could trigger catastrophic instability and insecurity, argues a new report published today by SIPRI.
Pascale Ferrier, of Quebec, has plead guilty to sending a threatening letter containing ricin to Donald Trump at the White House when he was president.
Emergent BioSolutions Inc. (NYSE:EBS) announced today a research award by the U.S. Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) to evaluate
Evotec SE have announced that the U.S. Department of Defense (“DOD”) has awarded Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to $ 49.9 m for the rapid development of monoclonal antibody (“mAb”)-based drug product prototypes targeting plague. Plague, an
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, today announced the exercise of procurement options under its 75A50118C00019 (19C) contract with the U.S. Department of Health and Human Services for the delivery to the U.S. government of intravenous (IV) formulation of
Infection from the enterohemorrhagic E. coli (EHEC) can cause bloody diarrhea and severe abdominal cramps in humans. This is due to the presence of a deadly toxin called “Shiga toxin” (Stx) produced by EHEC. Researchers from Japan have now discovered a compound that binds to and
DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively by the U.S. Department of Defense, U.S. Homeland Security, law enforcement, first responders and public health agencies around the world, today announce the launch of their MD-Bio
Swiss biotech Fastox Pharma will present for the first time its groundbreaking long-lasting botulinum toxin LAST technology at the leading conference on neurotoxins from July 27thto July 30th in New Orleans, USA.
Fastox has discovered that combining botulinum toxin type A (BoNT/A) with
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) awarded a total of $4,479,195.95 in competitive research contracts to 30 small businesses across the United
DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR assays using primers and probes synthesized by a customer via enzymatic synthesis using the company’s ...
The UK Health Security Agency has announced today it recommends offering the smallpox vaccine Imvanex, which is shown to be effective against monkeypox, to those considered to be at higher risk of exposure.
Teledyne FLIR Defense announced today at Eurosatory the launch of its new MUVE™ B330 drone payload that can be used to detect deadly biological agents and other airborne biohazards.
Chimerix, a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announces it has entered into a definitive agreement with Emergent BioSolutions Inc. (Emergent) to acquire its exclusive
SIGA Technologies, Inc. (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous (IV) formulation of TPOXX for the treatment of smallpox. The IV formulation is an important
BioFlyte, a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced that it raised $6.1M in new financing led by Cottonwood Technology Fund with additional funding from existing
Heat Biologics,Inc.(to be renamed “NightHawk Biosciences”), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it has completed the acquisition of Elusys
Masks, physical distancing, good hygiene, and ventilation can help reduce the transmission of COVID-19 in public places. But even when these measures are taken, scientists have sometimes detected SARS-CoV-2, the virus that causes COVID-19,
Scientists from Lawrence Livermore National Laboratory (LLNL) and three other institutions are seeking to develop a multi-pathogen vaccine that will protect against three bacterial biothreat pathogens.
In a time of daily confusion in the public discourse on the current pandemic, the Janne E. Nolan Center on Strategic Weapons, an institute of the Council on Strategic Risks (CSR), is releasing ...
Executives of a Japanese company indicted last year over illegal export of items capable of producing biological weapons will be compensated after the case against them was dropped, their lawyer said Thursday.
Teledyne FLIR announced it has won a development contract worth up to $15.7 million with the U.S. Defense Threat Reduction Agency’s Joint Science and Technology Office (DTRA JSTO) to develop novel battlefield threat mapping and visualization tools. The technology will allow the capability to
Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today unveiled its new RapidVax® cellular vaccine platform at the 2021 World Antiviral Congress. RapidVax is designed as a
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel
David Finlay, whose new book Coronadiary identifies that the COVID response was hindered by a lack of training for Ministers in core decision making skills and a failure to react to previous warnings to improve skills within government, calls for Ministers to receive professional training
According to recent reports, frozen vials labelled Smallpox have been found in a facility in Pensylvannia. Various news sources are reporting that 15 vials were "incidentally discovered" by a lab worker a Merck facility, 5 are labelled smallpox and the rest labelled vaccinia. The lab
The U.S. Department of Defense (DOD) awarded Dynavax Technologies Corporation with an agreement worth approximately $22 million over two and a half years, to execute a clinical trial combining the DOD’s recombinant plague (rF1V) vaccine with its own CpG 1018® adjuvant. Under the agreement,
Czech premium accessories brand Är has launched a reusable FFP2 certified mask treated with Polygiene ViralOffTM technology, to protect and self-clean the textile in regard to microbes. The mask also comes with an anti-fog system.
Smiths Detection, a global leader in threat detection and security screening technologies, today confirms that its air sampler, BioFlash, can detect SARS-CoV-2 variants including the Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1), the Kappa variant (B1.617.1), Delta
The Youtube news channel NTD ran a report on their channel in February of 2020 where they called and spoke to funeral directors in Wuhan about the numbers of deaths they were seeing.
Some of the answers are quite revealing, although it is what has been long suspected, that the
LexaGene Holdings, Inc. a molecular diagnostics company developing automated rapid polymerase chain reaction (PCR) testing solutions for veterinary diagnostics and biopharmaceutical
Physician-Scientist Steven Quay and a group of international scientists have published a paper, available here, regarding the contamination of Covid-19 patient samples at the Wuhan
Following on from the detection In 2015 and 2020 of two novel orthopox cases in the Fairbanks area of Alaska, the Alaska Department of Health and Social Services has recently reported that two additional infections were detected in July and August, of this year.
The research focused on three health zones in Ituri, where more than 490 cases were recorded between 2020 and 2021, with 20 fatalities. Some 578 cases, and 44 plague-related deaths, occurred throughout the entire province during the same period.
In the paste 6 weeks, the WHO has reported an additional 629 cases of Monkeypox in the Democratic Republic of Congo (DRC). There have also been six additional monkeypox fatalities reported.
From the beginning of the year through to August 8th, 2,523 cases have been reported
On August 18th the CDC announced a new center designed to advance the use of forecasting and outbreak analytics in public health decision making. Once established, the Center for Forecasting and Outbreak Analytics will bring together next-generation public health data, expert disease
Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces it has commenced development of a new biosecurity/biodefense initiative. The Company also announces it has formed an advisory board
U.S. Sen. Tammy Baldwin (D-WI) introduced legislation last week that would allocate $2 billion to the Biomedical Advanced Research and Development Authority (BARDA).
A recently queried case of Marburg virus in Guinea has now been confirmed. This is the first time the virus, a highly infectious disease that casuse hemorrhagic fever, had been detected in Guinea, and West Africa.
The patient sought treatment at a local clinic in Koundou, where a
Engineers from BAE Systems’ Submarines business, along with local company Lancastle and staff from University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT), have developed pioneering new Personal Protective Equipment (PPE) for staff on COVID-19 wards.
Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected. Their results are published online in the journal
As part of ongoing national preparedness efforts, BARDA has purchased and begun accepting delivery of the antibiotic NUZYRA (omadacycline) from Paratek Pharmaceuticals of Boston, Massachusetts, to treat infections caused by anthrax.
Deliberately-caused disease as a means of terrorism is a major threat which the scientific community and policymakers are not currently prepared to mitigate, say experts from the ...
Hand sanitizers and surface disinfectants have proven essential in the COVID-19 era but are also a critical means to reduce or prevent the spread of many infectious diseases. This is one of the reasons the Department of Homeland Security (DHS) is investing in a potentially fast, effective, and